VEGFA and cancer: High-systemicVEGF levels, present in most cancer patients, correlate with low DC frequencies[3, 4], while abnormally elevated numbers of immature DC precursors reportedlydecreased in three out of three cancer patients during treatment with theanti-VEGF antibody bevacizumab [3].